ProShare Advisors
WST icon

ProShare Advisors’s West Pharmaceutical WST Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$162M Buy
738,368
+235,272
+47% +$51.5M 0.32% 93
2025
Q1
$113M Sell
503,096
-74,872
-13% -$16.8M 0.25% 113
2024
Q4
$189M Sell
577,968
-533,588
-48% -$175M 0.43% 61
2024
Q3
$334M Buy
1,111,556
+644,750
+138% +$194M 0.82% 15
2024
Q2
$154M Sell
466,806
-33,856
-7% -$11.2M 0.41% 90
2024
Q1
$198M Buy
500,662
+61,247
+14% +$24.2M 0.53% 54
2023
Q4
$155M Sell
439,415
-49,350
-10% -$17.4M 0.47% 88
2023
Q3
$183M Buy
488,765
+7,889
+2% +$2.96M 0.57% 36
2023
Q2
$184M Sell
480,876
-193,264
-29% -$73.9M 0.53% 52
2023
Q1
$234M Sell
674,140
-27,520
-4% -$9.53M 0.71% 17
2022
Q4
$165M Buy
701,660
+182,459
+35% +$42.9M 0.58% 67
2022
Q3
$128M Buy
519,201
+28,876
+6% +$7.11M 0.49% 80
2022
Q2
$148M Buy
490,325
+67,170
+16% +$20.3M 0.49% 71
2022
Q1
$174M Buy
423,155
+54,851
+15% +$22.5M 0.37% 62
2021
Q4
$173M Sell
368,304
-17,537
-5% -$8.23M 0.34% 65
2021
Q3
$164M Sell
385,841
-34,603
-8% -$14.7M 0.46% 49
2021
Q2
$151M Buy
420,444
+31,745
+8% +$11.4M 0.44% 47
2021
Q1
$110M Buy
388,699
+373,227
+2,412% +$105M 0.34% 95
2020
Q4
$4.38M Buy
15,472
+1,245
+9% +$353K 0.02% 457
2020
Q3
$3.91M Sell
14,227
-893
-6% -$245K 0.02% 443
2020
Q2
$3.44M Sell
15,120
-80,651
-84% -$18.3M 0.02% 457
2020
Q1
$14.6M Sell
95,771
-22,879
-19% -$3.48M 0.1% 149
2019
Q4
$17.8M Sell
118,650
-4,533
-4% -$681K 0.08% 196
2019
Q3
$17.5M Buy
123,183
+4,289
+4% +$608K 0.1% 164
2019
Q2
$14.9M Buy
118,894
+9,820
+9% +$1.23M 0.09% 188
2019
Q1
$12M Buy
109,074
+25,093
+30% +$2.77M 0.07% 223
2018
Q4
$8.23M Sell
83,981
-3,905
-4% -$383K 0.06% 272
2018
Q3
$10.9M Sell
87,886
-64
-0.1% -$7.9K 0.07% 201
2018
Q2
$8.73M Buy
87,950
+283
+0.3% +$28.1K 0.06% 252
2018
Q1
$7.74M Sell
87,667
-27,236
-24% -$2.4M 0.05% 305
2017
Q4
$11.3M Buy
114,903
+8,783
+8% +$867K 0.08% 212
2017
Q3
$10.2M Sell
106,120
-12,932
-11% -$1.24M 0.09% 191
2017
Q2
$11.3M Buy
119,052
+4,255
+4% +$402K 0.11% 163
2017
Q1
$9.37M Buy
114,797
+17,617
+18% +$1.44M 0.1% 202
2016
Q4
$8.24M Buy
97,180
+34,952
+56% +$2.97M 0.09% 188
2016
Q3
$4.64M Buy
62,228
+24,794
+66% +$1.85M 0.06% 246
2016
Q2
$2.84M Sell
37,434
-536
-1% -$40.7K 0.04% 371
2016
Q1
$2.63M Buy
37,970
+14,934
+65% +$1.04M 0.04% 374
2015
Q4
$1.39M Buy
23,036
+4,879
+27% +$294K 0.02% 627
2015
Q3
$983K Buy
18,157
+2,265
+14% +$123K 0.01% 676
2015
Q2
$923K Sell
15,892
-4,714
-23% -$274K 0.01% 813
2015
Q1
$1.24M Sell
20,606
-36
-0.2% -$2.17K 0.01% 740
2014
Q4
$1.1M Sell
20,642
-11,506
-36% -$613K 0.01% 808
2014
Q3
$1.44M Sell
32,148
-7,841
-20% -$351K 0.02% 908
2014
Q2
$1.69M Sell
39,989
-34,079
-46% -$1.44M 0.02% 873
2014
Q1
$3.26M Buy
74,068
+65,950
+812% +$2.91M 0.04% 461
2013
Q4
$398K Sell
8,118
-38,914
-83% -$1.91M 0.01% 1096
2013
Q3
$1.94M Buy
47,032
+22,869
+95% +$941K 0.05% 418
2013
Q2
$1.7M Buy
+24,163
New +$1.7M 0.03% 536